Purpose To characterize the genetic architecture of left ventricular noncompaction (LVNC)
and investigate the extent to which it may represent a distinct pathology or a secondary …

Genetic testing for hypertrophic cardiomyopathy ( HCM ) is an established clinical technique,
supported by 30 years of research into its genetic etiology. Although pathogenic variants …

Background Differential diagnosis of genetic causes of left ventricular hypertrophy (LVH) is
crucial for disease-specific therapy. We aim to describe the prevalence of Cardiac …

Purpose Genetic testing in hypertrophic cardiomyopathy (HCM) has long relied on Sanger
sequencing of sarcomeric genes. The advent of next-generation sequencing (NGS) has …

The p.Val142Ile variant in transthyretin (encoded by the TTR gene) is the most common
genetic cause of transthyretin-related amyloidosis. This allele is particularly prevalent in …

Hypertrophic cardiomyopathy (HCM) is an important cause of morbidity and mortality with
both monogenic and polygenic components. We here report results from the largest HCM …

Background Left ventricular non-compaction (LVNC) is a condition characterised by
trabeculations in the myocardial wall and is the subject of considerable conjecture as to whether it …

: Hypertrophic cardiomyopathy (HCM) is an important cause of morbidity and mortality with
both monogenic and polygenic components. We here report results from the largest HCM …

Sudden cardiac death (SCD) is one of the most common causes of death; most SCD are
related to secondary arrhythmias, to structural heart disease, or to primary electrical …

The p.Val142Ile variant in transthyretin (encoded by the TTR gene) is the most common
genetic cause of transthyretin-related amyloidosis. This allele is particularly prevalent in …